KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Supply Is Limited and Distribution Uncertain as COVID Vaccine Rolls Out
Hospitals and nursing homes must decide who gets the initial doses as the U.S. heads into the biggest vaccination effort in history. There’s a lot left to figure out.
Farmworkers, Firefighters and Flight Attendants Jockey for Vaccine Priority
Everyone — from toilet paper manufacturers to patient advocates — is lobbying state advisory boards, arguing their members are essential, vulnerable or both — and, thus, most deserving of an early vaccine.
KHN’s ‘What the Health?’: Vaccines Coming Soon but COVID Relief Bill Still Stalled
Even as the Food and Drug Administration nears emergency authorization for the first vaccine to protect against COVID-19, Congress remains at loggerheads over a COVID relief bill that could also provide the funding to fully distribute the vaccines. Meanwhile, President-elect Joe Biden announced the first members of his health team. Joanne Kenen of Politico, Kimberly Leonard of Business Insider and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Mackert of the University of Texas-Austin, an expert on communicating public health information.
What Seniors Can Expect When COVID Vaccines Begin to Roll Out
At least two vaccines could get federal emergency use authorizations this month. Nursing home and assisted living residents will be among the first to receive inoculations. Here’s a guide on how that rollout may proceed.
Qué deben esperar los adultos mayores de la vacuna contra COVID
Adultos mayores en residencias y centros de vida asistida estarán entre los primeros en ser vacunados, siguiendo las recomendaciones de un panel asesor federal.
Demand for COVID Vaccines Expected to Get Heated — And Fast
With two vaccines against coronavirus disease poised for release within weeks, experts say they expect attitudes to shift dramatically from hesitancy to “Beanie Baby”-level urgency.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
KHN’s ‘What the Health?’: Who Will Run the Biden Health Effort?
The official transition to a Joe Biden administration has finally begun, and he is expected to announce his health care team soon, including a new secretary of Health and Human Services. Meanwhile, as the COVID-19 pandemic worsens in the U.S., officials are preparing for the effort to get Americans vaccinated as soon as vaccines are approved by the FDA. Alice Miranda Ollstein of Politico, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Julie Appleby, who wrote the latest KHN-NPR “Bill of the Month” installment.
Limpieza dental, gafas nuevas… y la vacuna contra COVID-19
Con múltiples vacunas de COVID-19 en camino, optometristas y dentistas presionan para que se autorice vacunar a los pacientes durante los exámenes oculares de rutina y las limpiezas dentales.
Feds Look to Pharmacists to Boost Childhood Immunization Rates
Fears over COVID-19 have contributed to a slump in inoculations among children. Now the federal government is looking to pharmacists for help, but many of them do not participate in a program that offers free shots to half the kids in the U.S.
Come for Your Eye Exam, Leave With a Band-Aid on Your Arm
Dentists and optometrists across the country are trying to join in the fight to get everyone vaccinated against COVID-19, the flu and other diseases.
How Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID
A Trump administration maneuver allows executives who are leading the federal effort to keep investments in drug companies that would benefit from the pandemic response.
Government-Funded Scientists Laid the Groundwork for Billion-Dollar Vaccines
Drugmakers will walk away with massive profits, but much of the pioneering work on mRNA vaccines was done with government money.
KHN’s ‘What the Health?’: Transition Interrupted
Former Vice President Joe Biden is now the president-elect nearly everywhere but inside the Trump administration, where the president refuses to concede and has ordered officials not to begin a formal transition. That is a particular problem for health care as the COVID-19 pandemic surges. Meanwhile, there’s good news on the vaccine front, but it’s unlikely one will arrive by winter. And the ACA was back before the Supreme Court — again. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Shefali Luthra of the 19th News join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Dicen que hay que informar a los consumidores, para que se preparen para efectos secundarios que, en realidad, pueden significar que las vacunas funcionan.
Time to Discuss Potentially Unpleasant Side Effects of COVID Shots? Scientists Say Yes.
From the likelihood of achy, flu-like side effects to the need for two doses, weeks apart, consumers need to know now what to expect when vaccines to prevent COVID-19 roll out.
Cinco preguntas críticas sobre la vacuna contra COVID-19 de Pfizer
La farmacéutica anunció que en una muestra pequeña se comprobó que podría prevenir la infección en nueve de cada 10 casos. Pero se necesitan más respuestas.
Five Important Questions About Pfizer’s COVID-19 Vaccine
The drugmaker says its mRNA vaccine worked in 90% of patients in its trial, but some observers question how long immunity will last and who will benefit.
As Nation Awaits Vaccine, Biden Is Under Pressure to Name New FDA Chief ASAP
It typically takes months to install new leadership, but with COVID deaths set to surge through the winter, many Democrats say Biden doesn’t have that sort of time.
